References
- Quinton J-F, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998;42: 788–91.
- Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999;134:447–52.
- Sonnenberg A. Occupational mortality of inflammatory bowel disease. Digestion 1990;46:10–8.
- Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut 1990;31:1037–40.
- Barclay GR, McKenzie H, Pennington J, Parratt D, Pennington CR. The effect of dietary yeast on the activity of stable chronic Crohn’s disease. Scand J Gastroenterol 1992;27:192–200.
- Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive infection with Saccharomyces cerevisiae. Rev Infect Dis 1990;12:406–11.
- Beier R, Gebert A. Kinetics of particle uptake in the domes of Peyer’s patches. Am J Physiol 1998;275:G130–7.
- Obayashi T, Yoshida M, Tamura H, Aketagawa J, Tanaka S, Kawai T. Determination of plasma (1–3)-β-D-glucan: a new diagnostic aid to deep mycosis. J Med Vet Mycol 1992;30:275–80.
- Obayashi T, Yoshida M, Hori T, Goto H, Yasuoka A, Iwasaki H, et al. Plasma (1–3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episode. Lancet 1995;345:17–20.
- Yoshida M, Obayashi T, Iwama A, Ito M, Tsunoda S, Suzuki T, et al. Detection of (1–3)-β-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol 1997;35:371–4.